Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
- PMID: 26366222
- PMCID: PMC4564040
Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
Abstract
A neurologic deficit of sudden onset conforming to a vascular territory is a clear clinical indication that a patient suffers from an acute stroke. However, the imagistic diagnostic confirmation is not always readily available. We are now able to offer comprehensive medical support for the patient after an acute stroke and to make a prodigious rehabilitation program after the damage is done, but this is not offering the chance for improvement. An opportunity to better diagnose ischemic stroke seems to be available by using neuronal biomarkers. Extensive research is being conducted in this field and useful information is beginning to gather. This mini-review aims to highlight selected studies that appear to be of particular interest for the clinical neurologist. The most promising biomarkers (or rather panels of biomarkers) are presented with theirs clinical usefulness and limitations.
Keywords: biomarker panel; early diagnosis; ischemic stroke; neuronal biomarker.
Similar articles
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study.Stroke. 2009 Jan;40(1):77-85. doi: 10.1161/STROKEAHA.108.516377. Epub 2008 Oct 23. Stroke. 2009. PMID: 18948614
-
Blood biomarkers in the early stage of cerebral ischemia.Rev Neurol (Paris). 2016 Mar;172(3):198-219. doi: 10.1016/j.neurol.2016.02.003. Epub 2016 Mar 14. Rev Neurol (Paris). 2016. PMID: 26988891 Review.
-
Plasma biomarkers in the diagnosis of acute ischemic stroke.Ann Clin Lab Sci. 2010 Fall;40(4):336-41. Ann Clin Lab Sci. 2010. PMID: 20947807
-
Blood Biomarkers for the Differentiation of Cardiac Ischemic Stroke Subtypes: A Systematic Review.Cardiovasc Hematol Disord Drug Targets. 2019;19(3):215-227. doi: 10.2174/1871529X18666180829142354. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 30160220
References
-
- Whiteley W, Tseng MC, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke. 2008;39:2902–2909. - PubMed
-
- Brouns R, De Deyn PP. The complexity of neurobiological processes in acute ischemic stroket. Clin Neurol Neurosurg. 2009;111:483–495. - PubMed
-
- Saenger KA, Christenson RH. Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment. Clinical Chemistry. 2010 Jan;56,1:21–33. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical